FairCap, a Germany based entrepreneurial investment company, has acquired Nyco Flexible Packaging, a Switzerland based manufacturer of advanced and sustainable packaging solutions for the food, beverage, household, personal care and healthcare industries, from Clondalkin Group,
Tags :Vischer
Vischer successfully represented a ship operator facing claims and lawsuits from sub-contractors alleging defaults. The demands could be repelled practically comprehensively. The Covid pandemic has hit the tourism industry particularly hard. This also applies to
On February 10, 2022, funds advised by Gilde Buy Out Partners has completed the investment in MBK Fincom, alongside the founders and management which are reinvesting in the business. With this transaction funds advised by Ardian, a
Nemis Technologies successfully completed a CHF 7.75m Series A financing round with the participation of both institutional and private investors. Nemis will use the investment funds to scale up its production, accelerate the ongoing international
A group of investors advised by Rigeto Unternehmerkapital (“Rigeto”) has acquired 100% of the shares in Laser Beauté Med, headquartered in Sion with additional locations in Monthey and Visp. The oldest dermatology clinic in the Swiss
Vischer has announced the appointment of Moritz Jäggy (pictured) as partner on 1 January 2022. Moritz Jäggy is a corporate lawyer with many years of experience in corporate law, sports law, real estate and start-ups.
A team from Vischer, led by partner Thomas Weibel (pictured), have taken part in the successful return of several million euros to Switzerland for a Swiss private bank, which had been transferred to an offshore
Anaveon, a Swiss clinical-stage immuno-oncology company, has agreed to a CHF 110 million Series B financing led by incoming investor Forbion, corner-stoned by founding investor Syncona, also joined by existing investor Novartis Venture Fund, as well
Bookselling company Orell Füssli Thalia acquired a stake as lead investor in the digital community platform Evrlearn. With the new partnership, both companies are strengthening their educational activities in B2C and B2B.
Alloy Therapeutics, a Boston based biotechnology ecosystem company, has entered into a definitive agreement to acquire deepCDR Biologics, a privately held Basel based developer of deep learning technology for antibody discovery and optimisation. Alloy will
